Levofloxacin Hydrochloride Eye Drops
Function and Efficacy
Levofloxacin is the levorotatory form of ofloxacin, and its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial topoisomerase IV and DNA gyrase (both are type II topoisomerases), hindering the replication of bacterial DNA to achieve antibacterial effects. Levofloxacin has the characteristics of a broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Serratia, Proteus, Shigella, Salmonella, Citrobacter, Acinetobacter, and Gram-negative bacteria such as Pseudomonas aeruginosa, Haemophilus influenzae, and Neisseria gonorrhoeae. It also has good antibacterial effects on some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Streptococcus pyogenes, hemolytic Streptococci, and Legionella, Mycoplasma, and Chlamydia, but has poor effects on anaerobic bacteria and enterococci.
Ingredients
Levofloxacin hydrochloride. Chemical name: (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyridinyl[1,2,3-de]-[1,4]-benzoxazine-6-carboxylic acid hydrochloride monohydrate
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Levofloxacin hydrochlorideIngredients |
It achieves antibacterial effect by inhibiting the activity of bacterial topoisomerase IV and DNA gyrase, hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, some methicillin-sensitive Staphylococci, Streptococcus pneumoniae, Legionella, Mycoplasma, Chlamydia, etc., but has poor effect on anaerobic bacteria and enterococci. More |
177325-13-2 | 18 |
Appearance
This product is a light yellow-green or slightly yellow clear liquid.
Indication
This product is suitable for the treatment of bacterial conjunctivitis and bacterial keratitis caused by sensitive bacteria.
Usage and Dosage
Drop the product into the conjunctival sac of the affected eye. 3-5 times a day, 1-2 drops each time. Recommended course of treatment: 7 days for bacterial conjunctivitis, 10-14 days for bacterial keratitis. Or follow the doctor's advice.
Adverse Reactions
The most commonly reported adverse reactions are temporary decreased vision, fever, headache, temporary eye heat, eye pain or discomfort, pharyngitis and photophobia, with an incidence of about 1%-3%. Other adverse reactions with an incidence of less than 1% include: allergy, eyelid edema, dry eyes and itching.
Precautions
1. It is contraindicated for patients who are allergic to levofloxacin hydrochloride or other quinolones and any components of this product; 2. It is used with caution by lactating women.
Special Population Medication
Precautions for children: The efficacy and safety of this product for infants under 1 year old have not been established. Oral administration of quinolones to immature animals can cause arthritis, but there is no evidence that levofloxacin eye drops have any effect on weight-bearing joints. Precautions for pregnancy and lactation: Use with caution in lactating women. Precautions for the elderly: There is no overall difference in the efficacy and safety of this product for the elderly and other adult patients.
Drug Interactions
There is still a lack of information on drug interactions with this product. However, it has been shown that some quinolones can increase the blood concentration of theophylline when administered systemically, interfere with the metabolism of caffeine, and increase the effects of oral anticoagulants such as warfarin and its derivatives. If cyclosporine is taken at the same time, patients may experience a transient increase in serum creatinine.
Storage
Keep in a light-proof and airtight container.
Packaging Specification
0.3% (calculated as C18H20FN3O4)
Validity Period
24 months
Manufacturer
Shandong Chenxin Fodu Pharmaceutical Co., Ltd.
-
Founded in:
2012-10-24 -
Address:
West side of the south end of Zhongdu Street, Wenshang County Economic Development Zone, Jining City, Shandong Province -
Tax NO.:
91370830056218957G -
Registered Funds:
108 million yuan -
Website:
-
Email: